Skip to Main Content

1,143

Views

0

CrossRef citations to date

0

Altmetric

Licensed Vaccines

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial

Neil Goldsteina Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

,

Chelsea McLeana Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsCorrespondence[email protected]
View further author information

,

Auguste Gaddahb Janssen Research & Development, Beerse, BelgiumView further author information

,

Joachim Douab Janssen Research & Development, Beerse, BelgiumView further author information

,

Babajide Keshinroa Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

,

Linda Bus-Jacobsa Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

,

Jenny Hendriksa Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

,

Kerstin Luhna Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

,

Cynthia Robinsona Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information

&

Macaya Douoguiha Janssen Vaccines & Prevention B.V, Leiden, The NetherlandsView further author information